Mounjaro (tirzepatide) is a prescription medicine authorised in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities, as an adjunct to reduced-calorie diet and increased physical activity
Journal of Neurotrauma , 34 (13), 2093-2099
Certain medical conditions can significantly impact weight management and loss
Transitioning to a different medication could help reignite your progress and get you back on track toward your goals
Individual variations in gastric emptying rates may contribute to the substantial inter-individual variability observed in clinical practice
Supporting blood sugar control , weight loss , and appetite regulation can indirectly lead to more consistent energy and improved overall vitality for some people